Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
MELDONIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MELDONIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTOSINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CYTOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
8J337D1HZY
Molecule Type:
Small molecule
Molecular Formula:
C4H5N3O
Molecular Weight:
111.1
AlogP:
-0.65
PSA:
71.77
HBD:
2.0
HBA:
#RotB:
0.0
Source:
IOPOFOSINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IOPOFOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DERSALAZINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DERSALAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
WS1IH75AJT
Molecule Type:
Small molecule
Molecular Formula:
C36H33N5O4
Molecular Weight:
599.69
AlogP:
7.53
PSA:
120.38
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BRILANESTRANT
(2)
Small molecule
Estrogen receptor alpha antagonist
Unknown
Investigational
Unknown
BRILANESTRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
9MM2R1A06R
Molecule Type:
Small molecule
Molecular Formula:
C26H20ClFN2O2
Molecular Weight:
446.91
AlogP:
6.82
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
6.0
Source:
HUPERZINE A
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
HUPERZINE A
×
Maximum Phase:
2
First Approval:
None
UNII:
0111871I23
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
2.0
PSA:
58.88
HBD:
2.0
HBA:
#RotB:
0.0
Source:
LARSUCOSTEROL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LARSUCOSTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
UGX2V7MGMZ
Molecule Type:
Small molecule
Molecular Formula:
C27H46O5S
Molecular Weight:
482.73
AlogP:
6.33
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AVAGACESTAT
(2)
Small molecule
Gamma-secretase inhibitor
Unknown
Investigational
Unknown
AVAGACESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
TQ44WWY45Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17ClF4N4O4S
Molecular Weight:
520.89
AlogP:
3.92
PSA:
119.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AMMONIUM TRICHLOROTELLURATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AMMONIUM TRICHLOROTELLURATE
×
Maximum Phase:
2
First Approval:
None
UNII:
708681952A
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CIPARGAMIN
(2)
Small molecule
P-type ATPase inhibitor
Unknown
Investigational
Unknown
CIPARGAMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Z7Q4FWA04P
Molecule Type:
Small molecule
Molecular Formula:
C19H14Cl2FN3O
Molecular Weight:
390.25
AlogP:
4.34
PSA:
56.92
HBD:
3.0
HBA:
#RotB:
0.0
Source:
TIRABRUTINIB
(2)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Investigational
Unknown
TIRABRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
LXG44NDL2T
Molecule Type:
Small molecule
Molecular Formula:
C25H22N6O3
Molecular Weight:
454.49
AlogP:
2.75
PSA:
108.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CENERIMOD
(2)
Small molecule
Sphingosine 1-phosphate receptor Edg-1 modulator
Unknown
Investigational
Unknown
CENERIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Y333RS1786
Molecule Type:
Small molecule
Molecular Formula:
C25H31N3O5
Molecular Weight:
453.54
AlogP:
4.07
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ILACIRNON
(2)
Small molecule
C-C chemokine receptor type 2 antagonist
Unknown
Investigational
Unknown
ILACIRNON
×
Maximum Phase:
2
First Approval:
None
UNII:
380F68J5PH
Molecule Type:
Small molecule
Molecular Formula:
C20H13ClF3N5O3S
Molecular Weight:
495.87
AlogP:
4.37
PSA:
117.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EXEPORFINIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EXEPORFINIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
R41ECT47G6
Molecule Type:
Small molecule
Molecular Formula:
C44H50N6O2+2
Molecular Weight:
694.92
AlogP:
8.94
PSA:
75.82
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ATEVIRDINE MESYLATE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
ATEVIRDINE MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
A948D8673W
Molecule Type:
Small molecule
Molecular Formula:
C21H25N5O2
Molecular Weight:
379.46
AlogP:
2.97
PSA:
73.49
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TENOFOVIR EXALIDEX
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
TENOFOVIR EXALIDEX
×
Maximum Phase:
2
First Approval:
None
UNII:
K7J545MEMA
Molecule Type:
Small molecule
Molecular Formula:
C28H52N5O5P
Molecular Weight:
569.73
AlogP:
6.86
PSA:
134.61
HBD:
2.0
HBA:
#RotB:
25.0
Source:
GSK239512
(2)
Small molecule
Histamine H3 receptor antagonist
Unknown
Investigational
Unknown
GSK239512
×
Maximum Phase:
2
First Approval:
None
UNII:
4I7U5C459M
Molecule Type:
Small molecule
Molecular Formula:
C23H27N3O2
Molecular Weight:
377.49
AlogP:
3.95
PSA:
45.67
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DU 125530
(2)
Small molecule
Serotonin 1a (5-HT1a) receptor antagonist
Unknown
Investigational
Unknown
DU 125530
×
Maximum Phase:
2
First Approval:
None
UNII:
ZB05V621UD
Molecule Type:
Small molecule
Molecular Formula:
C23H26ClN3O5S
Molecular Weight:
492.0
AlogP:
2.86
PSA:
79.39
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ISTAROXIME
(2)
Small molecule
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 activator
Unknown
Investigational
Unknown
ISTAROXIME
×
Maximum Phase:
2
First Approval:
None
UNII:
W8I9H2TPPL
Molecule Type:
Small molecule
Molecular Formula:
C21H32N2O3
Molecular Weight:
360.5
AlogP:
3.11
PSA:
81.75
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PESAMPATOR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PESAMPATOR
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIMYCIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CALCIMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
37H9VM9WZL
Molecule Type:
Small molecule
Molecular Formula:
C29H37N3O6
Molecular Weight:
523.63
AlogP:
5.53
PSA:
126.68
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PERILLYL ALCOHOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PERILLYL ALCOHOL
×
Maximum Phase:
2
First Approval:
None
UNII:
319R5C7293
Molecule Type:
Small molecule
Molecular Formula:
C10H16O
Molecular Weight:
152.24
AlogP:
2.28
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ISOPENTYL 2-CYANOACRYLATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ISOPENTYL 2-CYANOACRYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
3977IRA64J
Molecule Type:
Small molecule
Molecular Formula:
C9H13NO2
Molecular Weight:
167.21
AlogP:
1.66
PSA:
50.09
HBD:
0.0
HBA:
#RotB:
4.0
Source:
IMARIKIREN HYDROCHLORIDE
(2)
Small molecule
Renin inhibitor
Unknown
Investigational
Unknown
IMARIKIREN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
1NE31CW68S
Molecule Type:
Small molecule
Molecular Formula:
C27H42ClN5O4
Molecular Weight:
536.12
AlogP:
2.4
PSA:
88.93
HBD:
1.0
HBA:
#RotB:
10.0
Source:
PD-0299685
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PD-0299685
×
Maximum Phase:
2
First Approval:
None
UNII:
61SA6645RL
Molecule Type:
Small molecule
Molecular Formula:
C10H21NO2
Molecular Weight:
187.28
AlogP:
1.86
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MBX-2982
(2)
Small molecule
Glucose-dependent insulinotropic receptor agonist
Unknown
Investigational
Unknown
MBX-2982
×
Maximum Phase:
2
First Approval:
None
UNII:
B5TRY67L51
Molecule Type:
Small molecule
Molecular Formula:
C22H24N8OS
Molecular Weight:
448.56
AlogP:
3.43
PSA:
94.74
HBD:
0.0
HBA:
#RotB:
7.0
Source:
LEMUTEPORFIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LEMUTEPORFIN
×
Maximum Phase:
2
First Approval:
None
UNII:
EZ109VJ012
Molecule Type:
Small molecule
Molecular Formula:
C45H50N4O9
Molecular Weight:
790.91
AlogP:
6.84
PSA:
182.79
HBD:
3.0
HBA:
#RotB:
13.0
Source:
XL-999
(2)
Small molecule
Fibroblast growth factor receptor inhibitor
Unknown
Investigational
Unknown
XL-999
×
Maximum Phase:
2
First Approval:
None
UNII:
6I7PLF6N8L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VACTOSERTIB
(2)
Small molecule
TGF-beta receptor type I inhibitor
Unknown
Investigational
Unknown
VACTOSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
6T4O391P5Y
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN7
Molecular Weight:
399.43
AlogP:
4.24
PSA:
83.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ETIPREDNOL DICLOACETATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ETIPREDNOL DICLOACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
332VLD554F
Molecule Type:
Small molecule
Molecular Formula:
C24H30Cl2O6
Molecular Weight:
485.4
AlogP:
3.91
PSA:
89.9
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NCX-4016
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NCX-4016
×
Maximum Phase:
2
First Approval:
None
UNII:
EH04H13L6B
Molecule Type:
Small molecule
Molecular Formula:
C16H13NO7
Molecular Weight:
331.28
AlogP:
2.54
PSA:
104.97
HBD:
0.0
HBA:
#RotB:
6.0
Source:
APINOCALTAMIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
APINOCALTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OT-551
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
OT-551
×
Maximum Phase:
2
First Approval:
None
UNII:
DZ02S3A31N
Molecule Type:
Small molecule
Molecular Formula:
C13H23NO3
Molecular Weight:
241.33
AlogP:
2.35
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
2.0
Source:
KETOPROFEN SODIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
KETOPROFEN SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
5R10M39KS7
Molecule Type:
Small molecule
Molecular Formula:
C16H13NaO3
Molecular Weight:
276.27
AlogP:
3.11
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ZAPNOMETINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ZAPNOMETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
4RZD8LK83V
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(+)-SECOISOLARICIRESINOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
(+)-SECOISOLARICIRESINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
M8QRJ7JEJH
Molecule Type:
Small molecule
Molecular Formula:
C20H26O6
Molecular Weight:
362.42
AlogP:
2.12
PSA:
99.38
HBD:
4.0
HBA:
#RotB:
9.0
Source:
1
2
…
129
130
131
132
133
134
135
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA